Literature DB >> 11921694

The risk of radiocontrast nephropathy in patients with cirrhosis.

M Najjar1, A Hamad, M Salameh, A Agarwal, D A Feinfeld.   

Abstract

A retrospective case-control study was conducted to determine whether liver cirrhosis might be a risk factor for radiocontrast induced nephropathy as has been suggested. Data from 72 patients with cirrhosis and 72 patients without cirrhosis who all received 100-150 ml of low osmolality radiocontrast medium for abdominal or chest computerized tomography scan were reviewed. Blood urea nitrogen and creatinine were recorded before and 48-72 h after the administration of an intravenous radiocontrast agent. Acute renal failure developed in two patients with cirrhosis (2.8%) and one patient in the control group (1.4%). This difference was not significant. There was no significant change in blood urea nitrogen and creatinine in either group after radiocontrast injection. Both of the cirrhotic patients who developed radiocontrast induced nephropathy had received high-dose diuretics and were hypovolemic. We conclude that hepatic cirrhosis per se may not be a risk factor for radiocontrast-induced nephropathy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11921694     DOI: 10.1081/jdi-120002656

Source DB:  PubMed          Journal:  Ren Fail        ISSN: 0886-022X            Impact factor:   2.606


  7 in total

1.  The incidence of contrast-induced nephropathy (CIN) following transarterial chemoembolisation (TACE) in patients with hepatocellular carcinoma (HCC).

Authors:  Katsumi Hayakawa; Masato Tanikake; Toshihiko Kirishima; Naomi Yoshinami; Hiroyuki Shintani; Eiji Yamamoto; Taisuke Morimoto
Journal:  Eur Radiol       Date:  2014-02-13       Impact factor: 5.315

2.  No increased risk for contrast-induced nephropathy after multiple CT perfusion studies of the brain with a nonionic, dimeric, iso-osmolal contrast medium.

Authors:  S Langner; S Stumpe; M Kirsch; M Petrik; N Hosten
Journal:  AJNR Am J Neuroradiol       Date:  2008-06-04       Impact factor: 3.825

3.  Risk of contrast-induced nephropathy in hospitalized patients with cirrhosis.

Authors:  Nilesh Lodhia; Michael Kader; Thalia Mayes; Parvez Mantry; Benedict Maliakkal
Journal:  World J Gastroenterol       Date:  2009-03-28       Impact factor: 5.742

Review 4.  Kidneys in chronic liver diseases.

Authors:  Marek Hartleb; Krzysztof Gutkowski
Journal:  World J Gastroenterol       Date:  2012-06-28       Impact factor: 5.742

5.  Intravenous albumin for the prevention of contrast-induced nephropathy in patients with liver cirrhosis and chronic kidney disease undergoing contrast-enhanced CT.

Authors:  Heejung Choi; Yoonjung Kim; Soo Min Kim; Junam Shin; Hye Ryoun Jang; Jung Eun Lee; Wooseong Huh; Yoon-Goo Kim; Ha Young Oh; Dae Joong Kim
Journal:  Kidney Res Clin Pract       Date:  2012-04-23

6.  Acute kidney injury in cirrhotic patients undergoing contrast-enhanced computed tomography.

Authors:  Roberto Filomia; Sergio Maimone; Gaia Caccamo; Carlo Saitta; Luca Visconti; Angela Alibrandi; Simona Caloggero; Antonio Bottari; Maria Stella Franzè; Carmine Gabriele Gambino; Tindaro Lembo; Giovanni Oliva; Irene Cacciola; Giovanni Raimondo; Giovanni Squadrito
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889

7.  Radiocontrast-induced nephropathy in patients with liver cirrhosis and chronic kidney disease.

Authors:  Sang-Kyung Jo
Journal:  Kidney Res Clin Pract       Date:  2012-05-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.